These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35658941)

  • 1. Understanding and experience of adverse event following immunization (AEFI) and its consequences among healthcare providers in Kebbi State, Nigeria: a qualitative study.
    Omoleke SA; Getachew B; Isyaku A; Aliyu AB; Mustapha AM; Dansanda SM; Kanmodi KK; Abubakar H; Lawal ZI; Kangiwa HA
    BMC Health Serv Res; 2022 Jun; 22(1):741. PubMed ID: 35658941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse events following immunization: Findings from 2017/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017/2018 measles vaccination campaign.
    Gbenewei E; Nomhwange T; Taiwo L; Ayodeji I; Yusuf K; Jean Baptiste AE; Nsubuga P; Braka F; Oteri J; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C82-C88. PubMed ID: 33714655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare providers' knowledge, experience and challenges of reporting adverse events following immunisation: a qualitative study.
    Parrella A; Braunack-Mayer A; Gold M; Marshall H; Baghurst P
    BMC Health Serv Res; 2013 Aug; 13():313. PubMed ID: 23945045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse event following vaccine surveillance in Kaduna State, Northwestern Nigeria (January 2018 -June 2019): analysis of health facility´s records.
    Ishaku SG; Umeh G; Adzu B; Onimisi A; Dauda M; Iyal HA; Iliyasu N; Sunday DJ; Daikwo J; Yates SM; Ibrahim II; Samaila LH; Abdullahi B; Parom SK; Maiwashi KY; Zakari F; Nuhu KS
    Pan Afr Med J; 2021; 40():268. PubMed ID: 35251462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers to healthcare workers reporting adverse events following immunization in Zhejiang province, China.
    Lv H; Pan X; Wang Y; Liang H; Yu H
    Hum Vaccin Immunother; 2022 Nov; 18(5):2083865. PubMed ID: 35820038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of knowledge and reporting practices of primary healthcare workers on adverse experiences following immunisation in alimosho local government area, Lagos.
    Ogunyemi RA; Odusanya OO
    Niger Postgrad Med J; 2016; 23(2):79-85. PubMed ID: 27424618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine Safety and Surveillance for Adverse Events Following Immunization (AEFI) in India.
    Joshi J; Das MK; Polpakara D; Aneja S; Agarwal M; Arora NK
    Indian J Pediatr; 2018 Feb; 85(2):139-148. PubMed ID: 29170922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance for adverse events following immunization from 2008 to 2011 in Zhejiang Province, China.
    Hu Y; Li Q; Lin L; Chen E; Chen Y; Qi X
    Clin Vaccine Immunol; 2013 Feb; 20(2):211-7. PubMed ID: 23239804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine Immunization Consultant Program in Nigeria: A Qualitative Review of a Country-Driven Management Approach for Health Systems Strengthening.
    O'Connell M; Wonodi C
    Glob Health Sci Pract; 2016 Mar; 4(1):29-42. PubMed ID: 27016542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Potential Contribution of Supplementary Immunization Activities to Routine Immunization in Kebbi State, Nigeria.
    Omoleke SA; Getachew B; Igoh CS; Yusuf TA; Lukman SA; Loveday N
    J Prim Care Community Health; 2020; 11():2150132720932698. PubMed ID: 32508212
    [No Abstract]   [Full Text] [Related]  

  • 11. Implementation of data triangulation and dashboard development for COVID-19 vaccine adverse event following immunisation (AEFI) data in Nigeria.
    Shragai T; Adegoke OJ; Ikwe H; Sorungbe T; Haruna A; Williams I; Okonkwo R; Onu K; Asekun A; Gberikon M; Iwara E; Abimiku A; Rufai A; Okposen B; Gidudu J; Lam E; Bolu O
    BMJ Glob Health; 2023 Jan; 8(1):. PubMed ID: 36650016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse event following immunization (AEFI) surveillance in India, position paper of Indian Academy of Pediatrics,2013.
    Chitkara AJ; Thacker N; Vashishtha VM; Bansal CP; Gupta SG
    Indian Pediatr; 2013 Aug; 50(8):739-41. PubMed ID: 24036641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluatıon of adverse events following immunization reported during national immunization programs (Between 2017-2019 in Ankara Province).
    Simsek AÇ; Arabulan E; Tavukçu N; Çankaya S; Gulhan B; Ozkaya-Parlakay A
    Hum Vaccin Immunother; 2021 Jul; 17(7):2145-2148. PubMed ID: 33513052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: Understanding and experience of adverse event following immunization (AEFI) and its consequences among healthcare providers in Kebbi State, Nigeria: a qualitative study.
    Omoleke SA; Getachew B; Isyaku A; Aliyu AB; Mustapha AM; Dansanda SM; Kanmodi KK; Abubakar H; Lawal ZI; Kangiwa HA
    BMC Health Serv Res; 2022 Jul; 22(1):874. PubMed ID: 35799186
    [No Abstract]   [Full Text] [Related]  

  • 15. Deaths reported to national surveillance for adverse events following immunization in China, 2010-2015.
    Wu W; Liu D; Nuorti JP; Li K; Xu D; Ye J; Zheng J; Cao L; Wang H
    Vaccine; 2019 Feb; 37(9):1182-1187. PubMed ID: 30709723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of adverse events following an immunization campaign with the live, attenuated SA14-14-2 Japanese encephalitis vaccine in Cambodia.
    Hills SL; Soeung SC; Sarath S; Morn C; Dara C; Fischer M; Thigpen MC
    PLoS One; 2022; 17(6):e0269480. PubMed ID: 35679297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of death cases in Shenyang City, China, for immunization adverse event surveillance, 2009-2021.
    Gao D; Dong G; Zhu L; Jia N; Sun B
    Hum Vaccin Immunother; 2023 Aug; 19(2):2263225. PubMed ID: 37782096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of routine childhood vaccine coadministration versus separate vaccination.
    Bauwens J; de Lusignan S; Weldesselassie YG; Sherlock J; Künzli N; Bonhoeffer J
    BMJ Glob Health; 2022 Sep; 7(9):. PubMed ID: 36162867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.
    Clothier HJ; Crawford NW; Russell M; Kelly H; Buttery JP
    Drug Saf; 2017 Jun; 40(6):483-495. PubMed ID: 28342074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine surveillance of adverse events following immunization as an important tool to monitor vaccine safety.
    Alicino C; Merlano C; Zappettini S; Schiaffino S; Della Luna G; Accardo C; Gasparini R; Durando P; Icardi G
    Hum Vaccin Immunother; 2015; 11(1):91-4. PubMed ID: 25483520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.